{
    "2019-11-28": [
        [
            {
                "time": "",
                "original_text": "白云山获得23个药品再注册批件",
                "features": {
                    "keywords": [
                        "白云山",
                        "药品",
                        "再注册",
                        "批件",
                        "夏桑菊颗粒"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "白云山(00874)：星群药业收到夏桑菊颗粒等23个药品的《药品再注册批件》",
                "features": {
                    "keywords": [
                        "白云山",
                        "星群药业",
                        "夏桑菊颗粒",
                        "药品",
                        "再注册批件"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "白云山(600332.SH)：星群药业收到夏桑菊颗粒等23个药品的药品再注册批件",
                "features": {
                    "keywords": [
                        "白云山",
                        "星群药业",
                        "夏桑菊颗粒",
                        "药品",
                        "再注册批件"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "白云山：关于召开2020年第一次临时股东大会的通知",
                "features": {
                    "keywords": [
                        "白云山",
                        "股东大会",
                        "通知"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}